Literature DB >> 15606400

Oesophageal pH has a power-law distribution in control and gastro-oesophageal reflux disease subjects.

J D Gardner1, S Sloan, M Robinson, P B Miner.   

Abstract

BACKGROUND: We are unaware of any solid theoretical or pathophysiological basis for selecting pH 4 or any other pH value to assess oesophageal acid exposure or to define oesophageal reflux episodes. AIM: To examine the frequency of different oesophageal pH values in control and GERD subjects.
METHODS: Oesophageal pH was measured for 24 h in 57 gastro-oesophageal reflux disease subjects and 26 control subjects. Histograms were constructed using the 21,600 values from each recording and bins of 0.25 pH units.
RESULTS: Compared with controls, gastro-oesophageal reflux disease subjects had significantly more low pH values and significantly fewer high pH values. In both gastro-oesophageal reflux disease and control subjects, the frequency of oesophageal pH values was characterized by a power-law distribution indicating that the same relationship that describes low pH values also describes high pH values, as well as all values in between.
CONCLUSIONS: The distribution of oesophageal pH values indicates that a variety of different pH values can be used to assess oesophageal acid exposure, but raises important questions regarding how oesophageal reflux episodes are defined.

Entities:  

Mesh:

Year:  2004        PMID: 15606400     DOI: 10.1111/j.1365-2036.2004.02278.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  2 in total

1.  Exploring the physiologic role of human gastroesophageal reflux by analyzing time-series data from 24-h gastric and esophageal pH recordings.

Authors:  Luo Lu; John C Mu; Sheldon Sloan; Philip B Miner; Jerry D Gardner
Journal:  Physiol Rep       Date:  2014-07-16

2.  Metabolomic profiling of extraesophageal reflux disease in children.

Authors:  Lisa B Mahoney; Charles R Esther; Kara May; Rachel Rosen
Journal:  Clin Transl Sci       Date:  2021-05-31       Impact factor: 4.689

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.